Table 2

Demographic and clinical characteristics distributed by actual place of death (n=892)

All deathsActual place of death
Hospital n = 517 (58.0%)Home n = 178 (20.0%)Care home n = 106 (11.9%)Hospice n = 91 (10.2%)
Gender
Male (%)520 (58.3)319 (61.7)108 (60.7)42 (39.6)51 (56.0)
Age at death (years, %)
≤74363 (40.7)231 (44.7)80 (44.9)7 (6.6)45 (49.5)
75+529 (59.3)286 (55.3)98 (55.1)99 (93.4)46 (50.5)
IMD category* (%)
Most affluent1328 (36.8)196 (38.0)63 (35.4)35 (33.0)34 (37.4)
2303 (34.0)165 (32.0)64 (36.0)44 (41.5)30 (33.0)
Most deprived3260 (29.2)155 (30.0)51 (28.7)27 (25.5)27 (29.7)
First diagnosis (%)
DLBCL†129 (14.5)71 (13.7)23 (12.9)22 (20.8)13 (14.3)
Myeloma145 (16.3)90 (17.4)35 (19.7)11 (10.4)9 (9.9)
AML‡101 (11.3)61 (11.8)22 (12.4)7 (6.6)11 (12.1)
MDS§107 (12.0)69 (13.3)22 (12.4)6 (5.7)10 (11.0)
CLL¶89 (10.0)49 (9.5)18 (10.1)12 (11.3)10 (11.0)
MPN**79 (8.7)34 (6.6)20 (11.2)18 (17.0)6 (6.6)
Other243 (27.2)143 (27.7)38 (21.3)30 (28.3)32 (35.2)
Time from diagnosis to death (%)
0–6 months211 (23.7)138 (26.7)34 (19.1)27 (25.5)12 (13.2)
6+ months681 (76.3)379 (73.3)144 (80.9)79 (74.5)79 (86.8)
Underlying cause of death††
Haematological malignancy (%)602 (67.5)353 (68.3)117 (65.7)64 (60.4)68 (74.7)
Patient lived alone
Yes (%)247 (27.7)144 (27.9)45 (25.3)22 (20.8)36 (39.6)
Hospital-based SPC‡‡ referral
Yes (%)319 (35.8)167 (32.3)66 (37.1)19 (17.9)67 (73.6)
Preferred place of death discussion recorded
Yes (%)453 (50.8)217 (42.0)103 (57.9)61 (57.5)72 (79.1)
  • *Index of Multiple Deprivation (income domain): one patient with missing data.

  • †Diffuse large B-cell lymphoma.

  • ‡Acute myeloid leukaemia.

  • §Myelodysplastic syndromes.

  • ¶Chronic lymphocytic leukaemia.

  • **Myeloproliferative neoplasms.

  • ††Derived from death certificate data, Medical Research Information Service.

  • ‡‡Specialist palliative care.